Outcome Measures: |
Primary: Pre-dialysis serum phosphorus levels at 12 weeks, Week 12|Patient satisfaction questionnaire at 12 weeks, 7 question patient satisfaction questionnaire for participants to respond to how strongly they agree or disagree with their experience with the medication received in this clinical trial. Question are based on a 4 point ordinal scale of: Strongly Agree, Agree, Disagree, Strongly Disagree., Week 12|Physician satisfaction questionnaire at 12 weeks, 6 question physician satisfaction questionnaire for physicians to respond to how strongly they agree or disagree with their patient's experience with the medication received in this clinical trial. Question are based on a 4 point ordinal scale of: Strongly Agree, Agree, Disagree, Strongly Disagree., Week 12|Patient preference questionnaire at 12 weeks, 6 question patient preference questionnaire for participants to respond to whether they preferred the medication they received during this clinical trial or their previous medication., Week 12|Physician preference questionnaire at 12 weeks, 7 question physician preference questionnaire for physicians to respond to whether they preferred the medication administered during this clinical trial or their patient's previous medication., Week 12 |
|